VIIBRYD (vilazodone hydrochloride) Allergan Patent: 8,673,921 Expiration: Dec 5, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post D…
Drug Patent Expirations for the Week of December 4, 2022 Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Azurity drug NYMALIZE appeared first on DrugPate…
Annual Drug Patent Expirations for ELCYS Elcys is a drug marketed by Exela Pharma and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Exela Pharma drug ELCYS appeared first on DrugPatentWatch …
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New Patient Popul…
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. There is one patent protecting this drug. This drug has twenty…
The post New patent for Bioxcel drug IGALMI appeared first on DrugPatentWatch – M…
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. There is one patent protecting this drug. This drug has twenty…
The post New patent for Bioxcel drug IGALMI appeared first on DrugPatentWatch – M…
Annual Drug Patent Expirations for TUKYSA Tukysa is a drug marketed by Seagen and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Seagen drug TUKYSA appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for TUKYSA Tukysa is a drug marketed by Seagen and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Seagen drug TUKYSA appeared first on DrugPatentWatch…
Get new actionable insights and updates from BiotechBlog
